Senior Director, Global Quality jobs in United States
cer-icon
Apply on Employer Site
company-logo

DiscGenics · 1 week ago

Senior Director, Global Quality

DiscGenics is a pioneering biopharmaceutical company focused on regenerative cell-based therapies for degenerative spine diseases. They are seeking a Senior Director, Global Quality to oversee Quality Assurance, Quality Control, and Microbiology functions while driving the implementation of a globally compliant Quality Management System.

BiotechnologyHealth CareLife ScienceTherapeutics

Responsibilities

Serve as Management Representative for DiscGenics, including facilitation of Management Review. Identify trends in quality metrics to assess the effectiveness of the QMS and devise plans to improve quality systems
Develop and fully implement a Quality Management System that is compliant with FDA and applicable global market regulations
Navigate multiple regulatory requirements including FDA 21 CFR Parts 210/211, 600-680, 820, and 1271, Japan PMDA regulations, and ICH guidelines
Fully implement an electronic quality management system (eQMS) and/or other Quality information system to support compliance of quality systems
Establish and maintain design control, quality by design (QBD), and risk management programs
Qualify raw materials and components and their suppliers, and ensure quality agreements are in place
Oversee adherence to quality system, manufacturing batch records/SOP’s, and applicable in-process and final safety and release testing for IDCT cGMP dose manufacturing
Responsible for ensuring that documented evidence exists that demonstrates the conformance of products to pre-defined specification criteria and for release of such products
Execute external quality audits of suppliers as required per internal procedures
Supports clinical trial execution compliance to the appropriate SOP’s for both DGx and CRO vendors
Responsible for document control, internal quality audits, complaint and corrective action systems, supplier quality, and training
This individual is responsible for control of nonconforming products including their segregation, quarantine, disposition, and disposal, and is the Chairperson of and the Material Review Board
Build Quality (QA, QE, QC) staffing (inclusive of contractors) to support commercial facility and full cGMP readiness (inclusive of regulator audit readiness)
Maintains and evolves the Quality Control Analytical and Microbiology labs and the plant environmental monitoring program
Complete QA/QC and other applicable sections of US FDA, and Japanese PMDA and other regulatory submissions
Other duties as assigned

Qualification

Quality Management SystemCGMP complianceRegulatory submissionsInternal auditsTeam leadershipTechnical writingAttention to detailCommunication skillsCollaborationProblem-solving

Required

Experience with 21 CFR 211 and/or 21 CFR 820 and/or 21 CFR 1271
Familiarity and experience with International Conference of Harmonization (ICH) guidelines
Experience performing internal and/or external audits
Able to proactively identify quality gaps, and implement appropriate solutions that consider the needs of all company departments
Strong communication and technical writing skills
Impeccable attention to detail
Team leadership skills and team player
Adheres to and leads with the Company Values of Integrity, Innovation, Accuracy, Teamwork, and Stewardship
Regular and predictable attendance
Ability to report to work unimpaired
Minimum 8-10 years' experience in Quality Management in life sciences (directly in cell therapy, biologics, or other related biopharma sectors), with specific successful management experience in building and successfully implementing a QMS
Minimum bachelor's degree in relevant field, advanced degree preferred
Considerable experience with successful eQMS and/or other Quality information system RFP process, contract negotiations, implementation, and roll out

Preferred

Considerable experience with cell therapy comparability research and other forms of testing/analysis inclusive of release testing (including potency assay development) and stability testing preferred
Considerable experience in cell therapy cGMP manufacturing for both late-stage and clinical and commercial launch preferred (inclusive of BLA submission and approval)

Company

DiscGenics

twittertwittertwitter
company-logo
Regenerative Cell Therapy for Chronic Back Pain.

Funding

Current Stage
Growth Stage
Total Funding
$68M
Key Investors
Ci:z InvestmentMitsubishi UFJ Capital
2020-08-25Series C· $50M
2017-09-26Series B· $14M
2011-10-21Series A· $4M

Leadership Team

leader-logo
Kevin T. Foley
Board Member, Chief Medical Officer
linkedin
Company data provided by crunchbase